Literature DB >> 12521949

Drug treatment of hypertension.

Bryan Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12521949      PMCID： PMC1125015          DOI： 10.1136/bmj.326.7380.61

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  The renin angiotensin system and cardiovascular disease: hope or hype?

Authors:  B Williams
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2000-06       Impact factor: 1.636

Review 2.  Selected major risk factors and global and regional burden of disease.

Authors:  Majid Ezzati; Alan D Lopez; Anthony Rodgers; Stephen Vander Hoorn; Christopher J L Murray
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

3.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Authors:  William C Cushman; Charles E Ford; Jeffrey A Cutler; Karen L Margolis; Barry R Davis; Richard H Grimm; Henry R Black; Bruce P Hamilton; Joanne Holland; Chuke Nwachuku; Vasilios Papademetriou; Jeffery Probstfield; Jackson T Wright; Michael H Alderman; Robert J Weiss; Linda Piller; Judy Bettencourt; Sandra M Walsh
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

4.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

5.  Calcium-channel blockers for hypertension--uncertainty continues.

Authors:  J A Cutler
Journal:  N Engl J Med       Date:  1998-03-05       Impact factor: 91.245

6.  Use of ramipril in preventing stroke: double blind randomised trial.

Authors:  Jackie Bosch; Salim Yusuf; Janice Pogue; Peter Sleight; Eva Lonn; Badrudin Rangoonwala; Richard Davies; Jan Ostergren; Jeff Probstfield
Journal:  BMJ       Date:  2002-03-23

7.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

8.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

Authors:  B Neal; S MacMahon; N Chapman
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

9.  Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.

Authors: 
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

10.  British Hypertension Society guidelines for hypertension management 1999: summary.

Authors:  L E Ramsay; B Williams; G D Johnston; G A MacGregor; L Poston; J F Potter; N R Poulter; G Russell
Journal:  BMJ       Date:  1999-09-04
  10 in total
  7 in total

1.  Drug treatment of hypertension. Conclusion of editorial is somewhat flawed.

Authors:  Daniel G Hackam
Journal:  BMJ       Date:  2003-04-05

2.  Drug treatment of hypertension: implications of ALLHAT.

Authors:  B Williams
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

3.  Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats.

Authors:  Dinesh A Barawkar; Ashwin Meru; Anish Bandyopadhyay; Abir Banerjee; Anil M Deshpande; Chandrashekhar Athare; Chandrasekhar Koduru; Goraksha Khose; Jayasagar Gundu; Koshu Mahajan; Pradeep Patil; Sachin R Kandalkar; Sanjay Niranjan; Shubhangi Bhosale; Siddhartha De; Sudit Mukhopadhyay; Sumit Chaudhary; Summon Koul; Umesh Singh; Anita Chugh; Venkata P Palle; Kasim A Mookhtiar; Joseph Vacca; Prasun K Chakravarty; Ravi P Nargund; Samuel D Wright; Sophie Roy; Michael P Graziano; Sheo B Singh; Doris Cully; Tian-Quan Cai
Journal:  ACS Med Chem Lett       Date:  2011-10-07       Impact factor: 4.345

Review 4.  Hypertensive renal damage: insights from animal models and clinical relevance.

Authors:  Karen A Griffin; Anil K Bidani
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

5.  Patterns of antihypertensive drug utilization in primary care.

Authors:  D Pittrow; W Kirch; P Bramlage; H Lehnert; M Höfler; T Unger; A M Sharma; H-U Wittchen
Journal:  Eur J Clin Pharmacol       Date:  2004-03-20       Impact factor: 2.953

6.  Combinatorial Treatment Using Umbilical Cord Perivascular Cells and Aβ Clearance Rescues Vascular Function Following Transient Hypertension in a Rat Model of Alzheimer Disease.

Authors:  Paolo Bazzigaluppi; Tina L Beckett; Margaret M Koletar; Mary E Hill; Aaron Lai; Arunachala Trivedi; Lynsie Thomason; Adrienne Dorr; Denis Gallagher; Clifford L Librach; Illsung L Joo; JoAnne McLaurin; Bojana Stefanovic
Journal:  Hypertension       Date:  2019-09-03       Impact factor: 10.190

7.  Antihypertensive medication adherence and associated factors among adult hypertensive patients at Jimma University Specialized Hospital, southwest Ethiopia.

Authors:  Solomon Weldegebreal Asgedom; Tesfay Mehari Atey; Tigestu Alemu Desse
Journal:  BMC Res Notes       Date:  2018-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.